ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Elicio Announces IND for Vaccine Targeting Mutated KRAS Cancers americanpharmaceuticalreview
March 01, 2021Elicio Therapeutics has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for ELI-002. ELI-002 is an Amphiphile (AMP) KRAS therapeutic vaccine containing AMP mKRAS peptides and a proprietary AMP CpG ...
Pharma Sources Insight January 2025
